Advertisement
UK markets close in 5 hours 9 minutes

  • FTSE 100

    8,054.69
    +30.82 (+0.38%)
     

  • FTSE 250

    19,704.75
    +105.36 (+0.54%)
     

  • AIM

    752.23
    +3.05 (+0.41%)
     

  • GBP/EUR

    1.1593
    +0.0005 (+0.04%)
     

  • GBP/USD

    1.2362
    +0.0012 (+0.09%)
     

  • Bitcoin GBP

    53,512.71
    +65.45 (+0.12%)
     

  • CMC Crypto 200

    1,422.27
    +7.51 (+0.53%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CRUDE OIL

    81.92
    +0.02 (+0.02%)
     

  • GOLD FUTURES

    2,312.40
    -34.00 (-1.45%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • DAX

    18,007.75
    +146.95 (+0.82%)
     

  • CAC 40

    8,073.65
    +33.29 (+0.41%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

Global Mesothelioma Markets, Epidemiology and Patient Flow Report 2020-2035

Research and Markets
·2-min read

Dublin, May 18, 2021 (GLOBE NEWSWIRE) -- The "Global Mesothelioma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Mesothelioma Epidemiology and Patient Flow Analysis - 2021, provides Mesothelioma epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Mesothelioma patients, history of the disease at the population level (Mesothelioma prevalence, Mesothelioma incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Mesothelioma patient flow: Mesothelioma prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Mesothelioma patients by age group, gender

  • Forecast: Mesothelioma epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Mesothelioma market sizing, assessing market potential, and developing drug forecast models

  • Identify Mesothelioma patients segments through age groups, gender, and disease sub-types

  • Develop Mesothelioma population-based health management frameworks

  • Evaluate Mesothelioma market opportunities, identify target patient population

  • Align marketing decisions with the Mesothelioma target population

  • Communicate leadership and health authorities about your Mesothelioma target patient population

ADVERTISEMENT

Key Topics Covered:

1. Research Methodology

2. Mesothelioma Patients Definition

3. US Mesothelioma Epidemiology and Patient Flow

4. Germany Mesothelioma Epidemiology and Patient Flow

5. France Mesothelioma Epidemiology and Patient Flow

6. Italy Mesothelioma Epidemiology and Patient Flow

7. Spain Mesothelioma Epidemiology and Patient Flow

8. UK Mesothelioma Epidemiology and Patient Flow

9. Europe Mesothelioma Epidemiology and Patient Flow

10. Japan Mesothelioma Epidemiology and Patient Flow

11. Global Mesothelioma Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/ttatdl

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900